Amarin Corporation plc (NASDAQ:AMRN) traded at $1.75 at close of the session on Tuesday, 01/24/23, made a downward move of -2.78% on its previous day’s price.
Looking at the stock we see that its previous close was $1.80 with the day’s price range being $1.69 – $1.81. In terms of its 52-week price range, AMRN has a high of $3.82 and a low of $1.04. The company’s stock has gained about 40.00% over that past 30 days.
Amarin Corporation plc has a market cap of $714.42 million and is expected to release its quarterly earnings report on Oct 27, 2022. Estimates by analysts give the company expected earnings per share (EPS) of -$0.03, with the EPS growth for the year raised at -$0.29 for 2022 and -$0.17 for next year. These figures represent -1,550.00% and 41.40% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $86.45 million, with a low of $81 million and a high of $91.1 million. The median projection represents growth adding up to -40.20% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2022 is expected to hit $365.82 million, or -37.30% down from figures reported last year.
There have been 2 upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the AMRN stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 50% Buy. Long term indicators on average place the stock in the category of 50% Buy.
Based on estimates by 8 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 3 have rated the Amarin Corporation plc (AMRN) stock as a Hold, while 3 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 2 suggest the stock as a Sell. The stock has an overall rating of Hold and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 13.75% off its SMA20 and 30.56% from its 50-day simple moving average. The RSI (14) is pointing at 60.77 while the volatility over the past week is 8.62% and jumps to 8.78% over the past one month. The beta value is 1.83, while the average true range (ATR) is currently pointing at 0.14. The average price target for the stock over the next 12 months is $3.57, with the estimates having a low of $1.50 and a high of $9.00. These price ends are 14.29% and -414.29% off the current price level respectively, although investors could be excited at the prospect of a -71.43% if the AMRN share price touches on the median price of $3.00.
Let’s briefly compare Amarin Corporation plc (AMRN) stock to its peers. We find that current price change of -2.78% and -43.00% over the past 12 months for AMRN competes that of AstraZeneca PLC (AZN), which has seen its stock price fall -1.97% in the last trading session and was 12.15% over the last one year. Another of its peers Ionis Pharmaceuticals Inc. (IONS) has gained 1.65% previous session, and was 34.10% up over the past year, while AbbVie Inc. (ABBV) was also down -0.58% in the last session, while its price remained in the green at 11.90% over the same period.. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial were at -0.07% and 0.31%, respectively, at close of the trading.
Coming back to Amarin Corporation plc (NASDAQ:AMRN), we note that the average 3-month trading volume was 3.74 million, while that of the preceding 10-day period stands at 6.54 million. Current shares outstanding are 404.61 million.
The insiders hold 0.30% of the company’s shares while institutions hold 32.70%. The data shows that short shares as of Oct 13, 2022, stood at 9.59 million at a short ratio of 3.73. This represents a 2.38% short interest in shares outstanding on Oct 13, 2022. Shares short rose in October from the previous month at 9.56 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 44.63% up in year-to-date price movement.